flurazepam has been researched along with nimodipine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Tietz, EI; Xiang, K | 1 |
1 review(s) available for flurazepam and nimodipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for flurazepam and nimodipine
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Chronic benzodiazepine-induced reduction in GABA(A) receptor-mediated synaptic currents in hippocampal CA1 pyramidal neurons prevented by prior nimodipine injection.
Topics: Animals; Benzodiazepines; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Chelating Agents; Egtazic Acid; Excitatory Postsynaptic Potentials; Flurazepam; GABA Antagonists; GABA Modulators; Hippocampus; Hypnotics and Sedatives; In Vitro Techniques; Male; Nimodipine; Patch-Clamp Techniques; Presynaptic Terminals; Pyramidal Cells; Pyridines; Rats; Receptors, GABA-A; Zolpidem | 2008 |